Stock listing

NASDAQ:GDTC CytoMed Therapeutics Limited Stock

Home listing (NASDAQ) of CytoMed Therapeutics Limited

Follow CytoMed Therapeutics Limited into a list and get an email when it puts out news.

Share price · NASDAQ:GDTC

$0.755 USD -0.075 (-9.0%)

Close on Nov 20, 2026

Past year -58.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.713 – $0.785 USDNov 20, 2026
Volume
15,478 sharesNov 20, 2026
Market cap
$9.01M USDAt the close on Nov 20, 2026 · price × 11.93M shares outstanding
52-week range
$0.680 – $2.120 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$14,764 USDMedian day 11,900 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
CytoMed Therapeutics Limited logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:GDTC · Home$0.755 USD-0.075 (-9.0%)15,478$0.713$0.785$0.713$0.830Close on Nov 20, 2026
Frankfurt:F98€0.685 EUR-0.050 (-6.8%)—€0.670€0.685€0.670€0.735Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:GDTC · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.755-0.075-9.0%$0.713$0.785$0.71315,478
$0.830+0.047+6.0%$0.802$0.840$0.7905,090
$0.783+0.009+1.2%$0.760$0.805$0.70319,128
$0.774-0.055-6.7%$0.849$0.849$0.77114,768
$0.829-0.015-1.7%$0.800$0.829$0.7859,291
$0.844+0.004+0.5%$0.840$0.849$0.78615,595
$0.840+0.004+0.5%$0.836$0.840$0.82311,908
$0.836-0.023-2.7%$0.844$0.844$0.8298,742
$0.8590.0000.0%$0.830$0.859$0.83028,793
$0.859-0.021-2.4%$0.850$0.870$0.8008,887
$0.880-0.009-1.0%$0.812$0.890$0.8125,063
$0.889-0.021-2.3%$0.831$0.892$0.8316,383
$0.910+0.0000.0%$0.920$0.920$0.8525,178
$0.910-0.009-1.0%$0.911$0.920$0.85547,321
$0.919+0.018+2.0%$0.830$0.919$0.82911,444
$0.901-0.034-3.7%$0.863$0.930$0.85011,962
$0.935+0.045+5.1%$0.820$0.935$0.82010,118
$0.890-0.036-3.9%$0.890$0.893$0.85016,965
$0.926+0.007+0.8%$0.900$0.940$0.84512,490
$0.9190.0000.0%$0.840$0.919$0.8404,300
$0.9190.0000.0%$0.875$0.919$0.8225,900
$0.919+0.047+5.4%$0.811$0.919$0.8115,000
$0.872+0.020+2.3%$0.820$0.872$0.8128,300
$0.852-0.028-3.2%$0.850$0.865$0.84215,000
$0.880+0.010+1.1%$0.940$0.940$0.8407,300
$0.870+0.010+1.2%$0.806$0.880$0.7309,500
$0.860-0.010-1.1%$0.830$0.866$0.81010,600
$0.870+0.059+7.3%$0.865$0.880$0.81124,000
$0.811-0.079-8.9%$0.841$0.983$0.71054,800
$0.890-0.055-5.8%$0.939$0.940$0.85311,800
$0.945-0.035-3.6%$0.900$0.945$0.90023,200
$0.980+0.050+5.4%$0.900$0.980$0.80015,200
$0.930-0.080-7.9%$0.950$0.950$0.86518,600
$1.010+0.090+9.8%$0.845$1.060$0.84563,800
$0.920+0.020+2.2%$0.800$0.920$0.77033,700
$0.900+0.057+6.8%$0.843$0.900$0.8386,400
$0.843-0.046-5.2%$0.816$0.850$0.77013,000
$0.889-0.036-3.9%$0.851$0.891$0.81025,400
$0.925-0.030-3.1%$0.899$0.930$0.8496,500
$0.955+0.045+4.9%$0.910$0.955$0.88011,800
$0.9100.0000.0%$0.910$0.910$0.8565,400
$0.9100.0000.0%$0.876$0.910$0.8749,700
$0.910-0.060-6.2%$0.950$0.950$0.87032,300
$0.970-0.010-1.0%$0.970$0.970$0.81233,400
$0.980+0.094+10.6%$0.820$0.980$0.76620,700
$0.8860.0000.0%$0.842$0.886$0.7957,400
$0.886+0.081+10.1%$0.863$0.886$0.8064,300
$0.805-0.047-5.5%$0.852$0.852$0.80019,900
$0.852+0.070+9.0%$0.770$0.900$0.77012,500
$0.782-0.028-3.5%$0.838$0.838$0.77410,000
$0.810+0.015+1.9%$0.850$0.850$0.8009,100
$0.795-0.075-8.6%$0.853$0.930$0.79024,300
$0.870+0.009+1.0%$0.861$0.873$0.8233,900
$0.861-0.019-2.2%$0.930$0.930$0.85016,600
$0.8800.0000.0%$0.880$0.880$0.8800
$0.880-0.029-3.2%$0.851$0.900$0.85012,900
$0.9090.0000.0%$0.909$0.909$0.9090
$0.909-0.011-1.2%$0.919$0.919$0.76211,900
$0.920-0.030-3.2%$0.901$0.920$0.8602,500
$0.950-0.047-4.7%$0.980$0.988$0.95018,900
$0.997+0.062+6.6%$0.935$0.997$0.9102,800
$0.935-0.065-6.5%$1.000$1.000$0.92028,056
$1.000-0.030-2.9%$1.000$1.000$0.92874,011
$1.030+0.131+14.6%$0.803$1.030$0.80354,700
$0.899-0.001-0.1%$0.890$0.899$0.8605,400
Ticker
NASDAQ:GDTC
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • CytoMed Therapeutics (NASDAQ:GDTC) Q2 2025 Earnings Call

    Thu, Oct 02, 2025 · 10:00 AM ET

    Watch Transcript

Latest news

All CytoMed Therapeutics Limited news

Financings

  • Strategic investment of 10.0% post-money stake in subsidiary LongevityBank

    Nov 6, 2025

    Announced: up to US$500,000

    Buyers: ICH Capital Pte Ltd (up to US$500,000 for a 10.0% post-money stake in LongevityBank)

    Announced Nov 6, 2025

  • At-the-market programme of ordinary shares

    Aug 19, 2025

    Announced: up to US$4.3M · R.F. Lafferty & Co., Inc.

    Dealers: R.F. Lafferty & Co., Inc. (lead)

    Use of proceeds: General corporate purposes, possibly including business diversification and development initiatives and capital expenditures

    Announced Aug 19, 2025

Read by 6ix AI from the company's releases

Decks

CytoMed Therapeutics Limited on 6ix

Sector
Health care
Industry
Biotechnology
News releases
5 in the last 12 months · 39 in all · newest Oct 9, 2026 · oldest 2023
Calls
1 call with a replay · 1 with a transcript · latest Oct 2, 2025
Decks
1 deck · latest May 2023

Where CytoMed Therapeutics Limited is listed

ListingExchangeCountryCurrency
NASDAQ:GDTC · Home listing · This pageNASDAQUnited StatesUSD
BOATS:GDTCBOATSUnited StatesUSD
Frankfurt:F98FrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about CytoMed Therapeutics Limited.